In experimental models, inhibition of high-mobility group box-1 (HMGB1) signaling has been reported to protect against the sequelae of ischemic stroke. Here, we determined the clinical significance of serum HMGB1 levels in patients with acute ischemic stroke.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...